These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 16181731

  • 1. The prognostic role of loss of insulin-like growth factor-binding protein-3 expression in head and neck carcinogenesis.
    Papadimitrakopoulou VA, Brown EN, Liu DD, El-Naggar AK, Jack Lee J, Hong WK, Lee HY.
    Cancer Lett; 2006 Jul 28; 239(1):136-43. PubMed ID: 16181731
    [Abstract] [Full Text] [Related]

  • 2. Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer.
    Chang YS, Kong G, Sun S, Liu D, El-Naggar AK, Khuri FR, Hong WK, Lee HY.
    Clin Cancer Res; 2002 Dec 28; 8(12):3796-802. PubMed ID: 12473592
    [Abstract] [Full Text] [Related]

  • 3. Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer.
    Chang YS, Wang L, Liu D, Mao L, Hong WK, Khuri FR, Lee HY.
    Clin Cancer Res; 2002 Dec 28; 8(12):3669-75. PubMed ID: 12473575
    [Abstract] [Full Text] [Related]

  • 4. The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer.
    Han JY, Choi BG, Choi JY, Lee SY, Ju SY.
    Lung Cancer; 2006 Nov 28; 54(2):227-34. PubMed ID: 16935391
    [Abstract] [Full Text] [Related]

  • 5. [Expression and prognostic significance in epithelial ovarian cancer].
    Katsaros D, Yu H, Piccinno R, Puopolo M, Rigault De La Longrais IA, Fracchioli S, Massobrio M.
    Minerva Ginecol; 2002 Feb 28; 54(1):15-24. PubMed ID: 11828267
    [Abstract] [Full Text] [Related]

  • 6. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer.
    Han CH, Cho JY, Moon JT, Kim HJ, Kim SK, Shin DH, Chang J, Ahn CM, Kim SK, Chang YS.
    Oncol Rep; 2006 Dec 28; 16(6):1205-10. PubMed ID: 17089038
    [Abstract] [Full Text] [Related]

  • 7. Insulin-like growth factor binding protein-5 (IGFBP-5) suppresses the tumourigenesis of head and neck squamous cell carcinoma.
    Hung PS, Kao SY, Shih YH, Chiou SH, Liu CJ, Chang KW, Lin SC.
    J Pathol; 2008 Feb 28; 214(3):368-76. PubMed ID: 18085517
    [Abstract] [Full Text] [Related]

  • 8. Stromal syndecan-1 expression is an adverse prognostic factor in oral carcinomas.
    Máthé M, Suba Z, Németh Z, Tátrai P, Füle T, Borgulya G, Barabás J, Kovalszky I.
    Oral Oncol; 2006 May 28; 42(5):493-500. PubMed ID: 16364677
    [Abstract] [Full Text] [Related]

  • 9. Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck.
    Clauditz TS, Wang CJ, Gontarewicz A, Blessmann M, Tennstedt P, Borgmann K, Tribius S, Sauter G, Dalchow C, Knecht R, Münscher A, Wilczak W.
    J Oral Pathol Med; 2013 Feb 28; 42(2):125-32. PubMed ID: 22643116
    [Abstract] [Full Text] [Related]

  • 10. The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer.
    Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Risch HA, Puopolo M, Yu H.
    Clin Cancer Res; 2006 Feb 15; 12(4):1208-14. PubMed ID: 16489075
    [Abstract] [Full Text] [Related]

  • 11. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
    Boonkitticharoen V, Kulapaditharom B, Leopairut J, Kraiphibul P, Larbcharoensub N, Cheewaruangroj W, Chintrakarn C, Pochanukul L.
    Arch Otolaryngol Head Neck Surg; 2008 Dec 15; 134(12):1305-11. PubMed ID: 19075127
    [Abstract] [Full Text] [Related]

  • 12. Chromatin assembly factor-1 (CAF-1)-mediated regulation of cell proliferation and DNA repair: a link with the biological behaviour of squamous cell carcinoma of the tongue?
    Staibano S, Mignogna C, Lo Muzio L, Mascolo M, Salvatore G, Di Benedetto M, Califano L, Rubini C, De Rosa G.
    Histopathology; 2007 Jun 15; 50(7):911-9. PubMed ID: 17543081
    [Abstract] [Full Text] [Related]

  • 13. Akt activation correlates with adverse outcome in tongue cancer.
    Massarelli E, Liu DD, Lee JJ, El-Naggar AK, Lo Muzio L, Staibano S, De Placido S, Myers JN, Papadimitrakopoulou VA.
    Cancer; 2005 Dec 01; 104(11):2430-6. PubMed ID: 16245318
    [Abstract] [Full Text] [Related]

  • 14. Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.
    Lu L, Katsaros D, Wiley A, de la Longrais IA, Puopolo M, Yu H.
    Cancer Invest; 2008 Mar 01; 26(2):185-92. PubMed ID: 18259951
    [Abstract] [Full Text] [Related]

  • 15. [Postoperative recurrence-related factors of 125 patients with cT1-2N0 squamous cell carcinoma of the oral tongue].
    Han JM, Wu GH, Zeng ZY, Chen FJ, Chen WK, Li H, Song M, Sun CZ.
    Ai Zheng; 2007 Jun 01; 26(6):661-5. PubMed ID: 17562277
    [Abstract] [Full Text] [Related]

  • 16. Epidemiological and histopathological data and E-cadherin-like prognostic factors in early carcinomas of the tongue and floor of mouth.
    Menezes MB, Lehn CN, Gonçalves AJ.
    Oral Oncol; 2007 Aug 01; 43(7):656-61. PubMed ID: 17350325
    [Abstract] [Full Text] [Related]

  • 17. Fragile histidine triad expression in oral squamous cell carcinoma and precursor lesions.
    Kujan O, Oliver R, Roz L, Sozzi G, Ribeiro N, Woodwards R, Thakker N, Sloan P.
    Clin Cancer Res; 2006 Nov 15; 12(22):6723-9. PubMed ID: 17121892
    [Abstract] [Full Text] [Related]

  • 18. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma.
    Honjo Y, Inohara H, Akahani S, Yoshii T, Takenaka Y, Yoshida J, Hattori K, Tomiyama Y, Raz A, Kubo T.
    Clin Cancer Res; 2000 Dec 15; 6(12):4635-40. PubMed ID: 11156213
    [Abstract] [Full Text] [Related]

  • 19. High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx.
    Järvinen AK, Autio R, Kilpinen S, Saarela M, Leivo I, Grénman R, Mäkitie AA, Monni O.
    Genes Chromosomes Cancer; 2008 Jun 15; 47(6):500-9. PubMed ID: 18314910
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue.
    Hassan KA, El-Naggar AK, Soria JC, Liu D, Hong WK, Mao L.
    Clin Cancer Res; 2001 Aug 15; 7(8):2458-62. PubMed ID: 11489826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.